Similar articles

• Impact of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the long-term outcome after pulmonary vein isolation for paroxysmal atrial fibrillation.

  Klemm HU, Heitzer T, Ruprecht U, Meinertz T, Ventura R. Klemm HU, et al. Cardiology. 2010;117(1):14-20. doi: 10.1159/000318016. Epub 2010 Sep 29. Cardiology. 2010. PMID: 20881389
• Renin-angiotensin system blocker use may be associated with suppression of atrial fibrillation recurrence after pulmonary vein isolation.

  Ishikawa K, Yamada T, Yoshida Y, Takigawa M, Aoyama Y, Inoue N, Tatematsu Y, Nanasato M, Kato K, Tsuboi N, Hirayama H. Ishikawa K, et al. Pacing Clin Electrophysiol. 2011 Mar;34(3):296-303. doi: 10.1111/j.1540-8159.2010.02949.x. Epub 2010 Nov 22. Pacing Clin Electrophysiol. 2011. PMID: 21091729
• Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.

  Richter B, Derntl M, Marx M, Lercher P, Gössinger HD. Richter B, et al. Am Heart J. 2007 Jan;153(1):113-9. doi: 10.1016/j.ahj.2006.09.006. Am Heart J. 2007. PMID: 17174648
• ARBs, ACE-Is, or statins after catheter ablation of atrial fibrillation?

  Deneke T. Deneke T. J Cardiovasc Electrophysiol. 2007 Sep;18(9):947-9. doi: 10.1111/j.1540-8167.2007.00917.x. Epub 2007 Jul 30. J Cardiovasc Electrophysiol. 2007. PMID: 17666057 Review. No abstract available.
• Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis.

  Huang G, Xu JB, Liu JX, He Y, Nie XL, Li Q, Hu YM, Zhao SQ, Wang M, Zhang WY, Liu XR, Wu T, Arkin A, Zhang TJ. Huang G, et al. Eur J Clin Invest. 2011 Jul;41(7):719-33. doi: 10.1111/j.1365-2362.2010.02460.x. Epub 2011 Jan 20. Eur J Clin Invest. 2011. PMID: 21250983 Review.